https://blog.lifesciencenation.com/2026/06/30/hot-investor-mandate-early-stage-focused-fund-invests-in-seed-to-series-a-rounds-in-digital-health-and-healthtech-companies/Next Phase Newsletteren2026-06-30T16:23:12+00:00Hot Investor Mandate: Early-Stage Focused Fund Invests in Seed to Series A Rounds in Digital Health and Healthtech Companiestechnology, health, AI, business, entrepreneurship, finance, investing, artificial-intelligencehttps://blog.lifesciencenation.com/2026/06/30/hot-investor-mandate-private-investment-firm-with-asset-centric-approach-invests-in-promising-early-stage-therapeutics-assets/Next Phase Newsletteren2026-06-30T16:22:40+00:00Hot Investor Mandate: Private Investment Firm with Asset-Centric Approach Invests in Promising Early-Stage Therapeutics Assetstechnology, health, AI, business, entrepreneurship, finance, investing, artificial-intelligencehttps://blog.lifesciencenation.com/2026/06/30/hot-investor-mandate-asia-based-vc-firm-invests-in-early-and-growth-stage-opportunities-in-life-sciences-open-to-cross-border-investment/Next Phase Newsletteren2026-06-30T16:22:13+00:00Hot Investor Mandate: Asia-Based VC Firm Invests in Early and Growth-Stage Opportunities in Life Sciences, Open to Cross Border Investmenttechnology, health, AI, business, entrepreneurship, finance, investing, artificial-intelligencehttps://blog.lifesciencenation.com/2026/06/30/hot-investor-mandate-pharma-corporate-venture-arm-makes-strategic-investments-in-therapeutics-companies-focusing-on-pre-clinical-stage/Next Phase Newsletteren2026-06-30T16:21:38+00:00Hot Investor Mandate: Pharma Corporate Venture Arm Makes Strategic Investments in Therapeutics Companies, Focusing on Pre-Clinical Stagetechnology, health, AI, business, entrepreneurship, finance, investing, artificial-intelligence